As of November 12, 2026, Ibogaine is illegal to sell (federally scheduled; state law on file reads illegal) in New Jersey. Schedule I federally (21 CFR 1308.11(d)(21)); 2026 research push, no approval. Controlling source: N.J.S.A. 24:21-5 e. (Schedule I, hallucinogenic substances).
Verified November 12, 2026 (hash check) · confidence: confirmedIs Ibogaine Legal? Every state and federal law
New Jersey Ibogaine ban status: ban in force
New Jersey Schedule I (N.J.S.A. 24:21-5 e.) names ibogaine (8) under a lead-in reaching any material, compound, mixture or preparation which contains any quantity of it, so iboga root bark containing ibogaine is captured; Tabernanthe iboga is not named. No New Jersey ibogaine research or funding law was found (full N.J.S.A. search), and noribogaine is not named. N.J.S.A. 2C:35-2 treats a controlled substance analog (a substance with a chemical structure substantially similar to a controlled dangerous substance and specifically designed to produce a substantially similar effect) as a controlled dangerous substance. See the federal page.
e. Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: ... (8) Ibogaine
Among New Jersey's 3 neighbors, Delaware, New York and Pennsylvania are illegal, the same posture as New Jersey.
Open the interactive map · Every compound in New Jersey · Where Ibogaine is banned · Embed this map
Federally scheduled or prohibited. Schedule I federally (21 CFR 1308.11(d)(21)); 2026 research push, no approval Federal detail
10 instruments on file for this compound’s framework in New Jersey; 4 of 4 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
022dab234cde3160d. Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Alphaprodine (2) Anileridine (3) Bezitramide (4) Dihydrocodeine (5) Diphenoxylate (6) Fentanyl (7) Isomethadone (8) Levomethorphan (9) Levorphanol (10) Metazocine (11) Methadone (12) Methadone--Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane (13) Moramide--Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid (14) Pethidine (15) Pethidine--Intermediate--A, 4-cyano-1-methyl-4-phenylpiperidine (16) Pethidine--Intermediate--B, ethyl-4-phenylpiperidine-4-carboxylate (17) Pethidine--Intermediate--C, 1-methyl-4-phenylpiperidine-4-carboxylic acid (18) Phenazocine (19) Piminodine (20) Racemethorphan (21) Racemorphan (22) Tianeptine and any salt, sulfate, free acid, or other preparation of tianeptine and any salt, sulfate, free acid, compound, derivative, precursor, or other preparation thereof that is substantially chemically equivalent or identical with tianeptine.
634785e900e19af8Although New Jersey has adopted, in N.J.A.C. 13:45H-10.1(a), the Federal controlled dangerous substances Schedules I through V codified at 21 CFR 1308.11 through 1308.15, as amended and supplemented, the Director is authorized under N.J.S.A. 24:21-3 to add, delete, or reschedule substances under the New Jersey Controlled Dangerous Substances Act. Full text of the adoption follows: 13:45H-10.1 Schedules of controlled dangerous substances (a)-(d) (No change.) (e) In accordance with (d) above, the following substances shall be designated and controlled as Schedule I controlled dangerous substances: 1.-9. (No change.) 10. Illicit fentanyls. Illicit fentanyls include any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedules I through V, is not a Federal Food and Drug Administration (FDA) approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues (analogs), and salts of isomers, and homologues (analogs) unless specifically excepted whenever the existence of these salts, isomers, homologues (analogs), and salts of isomers and homologues (analogs) is possible within the specific chemical designations: i. Furanyl Fentanyl, with a chemical composition of N-phenyl-N-[1-(2-phenylethyl)-4- piperidinyl] -2-furancarboxamide, monohydrochloride or N-(1-phenethylpiperidin-4-yl)-N- phenylfuran-2-carboxamide; ii. 3-Methylfentanyl, with a chemical composition of 3-methyl-N-phenyl-N-[1-(2-phenethyl- 4-piperidyl)-propanamide); iii. 3-Methyl Butyrylfentanyl, with a chemical composition of 3-Methyl, N-phenyl-N-[1-(2- phenylethyl)-4-piperidinyl]-butanamide, monohydrochloride; iv. Valeryl Fentanyl, with a chemical composition of N-phenyl-N-[1-(2-phenylethyl)-4- piperidinyl]-pentanamide, monohydrochloride; v. Norfentanyl, with a chemical composition of N-phenyl-N-4-piperidinyl-propanamide; vi. Para-Fluorobutyryl-Fentanyl, with a chemical composition of N-(4-fluorophenyl)-N-[1-(2- phenylethyl)-4-piperidinyl]-butanamide, monohydrochloride; and vii. Carfentanyl, with a chemical composition of 2-hydroxypropane-1, 2, 3-tricarboxylic acid; methyl 1-(2-phenylethyl)-4-(N-propanoylanilino) piperidine-4-carboxylateor.
d01c396e91a3602bIf any substance is designated, rescheduled or deleted as a controlled dangerous substance under federal law and notice thereof is given to the director, the director shall similarly control the substance under P.L.1970, c.226, as amended and supplemented, after the expiration of 30 days from publication in the Federal Register of a final order designating a substance as a controlled dangerous substance or rescheduling or deleting a substance, unless within that 30-day period, the director objects to inclusion, rescheduling, or deletion. In that case, the director shall cause to be published in the New Jersey Register and made public the reasons for his objection and shall afford all interested parties an opportunity to be heard. At the conclusion of any such hearing, the director shall publish and make public his decision, which shall be final unless the substance is specifically otherwise dealt with by an act of the Legislature. Upon publication of objection to inclusion or rescheduling under P.L.1970, c.226 (C.24:21-1 et seq.) by the director, control of such substance under this section shall automatically be stayed until such time as the director makes public his final decision.
c4701937bc6edc5824:21-5 Schedule I. 5. a. Tests. The director shall place a substance in Schedule I if he finds that the substance: (1) has high potential for abuse; and (2) has no accepted medical use in treatment in the United States; or lacks accepted safety for use in treatment under medical supervision. b. The controlled dangerous substances listed in this section are included in Schedule I, subject to any revision and republishing by the director pursuant to subsection d. of section 3 of P.L.1970, c.226 (C.24:21-3), and except to the extent provided in any other schedule. c. Any of the following opiates, including their isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: (1) Acetylmethadol (2) Allylprodine (3) Alphacetylmethadol (4) Alphameprodine (5) Alphamethadol (6) Benzethidine (7) Betacetylmethadol (8) Betameprodine (9) Betamethadol (10) Betaprodine (11) Clonitazene (12) Dextromoramide (13) Dextrorphan (14) Diampromide (15) Diethylthiambutene (16) Dimenoxadol (17) Dimepheptanol (18) Dimethylthiambutene (19) Dioxaphetyl butyrate (20) Dipipanone (21) Ethylmethylthiambutene (22) Etonitazene (23) Etoxeridine (24) Furethidine (25) Hydroxypethidine (26) Ketobemidone (27) Levomoramide (28) Levophenacylmorphan (29) Morpheridine (30) Noracymethadol (31) Norlevorphanol (32) Normethadone (33) Norpipanone (34) Phenadoxone (35) Phenampromide (36) Phenomorphan (37) Phenoperidine (38) Piritramide (39) Proheptazine (40) Properidine (41) Racemoramide (42) Trimeperidine. d. Any of the following narcotic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation: (1) Acetorphine (2) Acetylcodone (3) Acetyldihydrocodeine (4) Benzylmorphine (5) Codeine methylbromide (6) Codeine-N-Oxide (7) Cyprenorphine (8) Desomorphine (9) Dihydromorphine (10) Etorphine (11) Heroin (12) Hydromorphinol (13) Methyldesorphine (14) Methylhydromorphine (15) Morphine methylbromide (16) Morphine methylsulfonate (17) Morphine-N-Oxide (18) Myrophine (19) Nicocodeine (20) Nicomorphine (21) Normorphine (22) Phoclodine (23) Thebacon. e. Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) 3,4-methylenedioxy amphetamine (2) 5-methoxy-3,4-methylenedioxy amphetamine (3) 3,4,5-trimethoxy amphetamine (4) Bufotenine (5) Diethyltryptamine (6) Dimethyltryptamine (7) 4-methyl-2,5-dimethoxylamphetamine (8) Ibogaine (9) Lysergic acid diethylamide (10) Marijuana; except that on and after the effective date of the "New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act," P.L.2021, c.16 (C.24:6I-31 et al.), marijuana shall no longer be included in Schedule I and shall not be designated or rescheduled and included in any other schedule by the director pursuant to the director’s designation and rescheduling authority set forth in section 3 of P.L.1970, c.226 (C.24:21-3). (11) Mescaline (12) Peyote (13) N-ethyl-3-piperidyl benzilate (14) N-methyl-3-piperidyl benzilate (15) Psilocybin (16) Psilocyn (17) Tetrahydrocannabinols, including those produced by way of manufacture, except when found in hemp or a hemp product cultivated, handled, processed, transported, or sold pursuant to the "New Jersey Hemp Farming Act," P.L.2019, c.238 (C.4:28-6 et al.), or cannabis or a cannabis item, as those terms are defined in section 3 of P.L.2021, c.16 (C.24:6I-33), that is grown, cultivated, produced, manufactured, or sold in accordance with the "New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act," P.L.2021, c.16 (C.24:6I-31 et al.). L.1970, c.226, s.5; amended 2007, c.244, s.3; 2018, c.139, s.8; 2019, c.238, s.12; 2021, c.16, s.44; 2024, c.73, s.3.
8bdc42588705220fe. Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) 3,4-methylenedioxy amphetamine (2) 5-methoxy-3,4-methylenedioxy amphetamine (3) 3,4,5-trimethoxy amphetamine (4) Bufotenine (5) Diethyltryptamine (6) Dimethyltryptamine (7) 4-methyl-2,5-dimethoxylamphetamine (8) Ibogaine (9) Lysergic acid diethylamide (10) Marijuana; except that on and after the effective date of the "New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act," P.L.2021, c.16 (C.24:6I-31 et al.), marijuana shall no longer be included in Schedule I and shall not be designated or rescheduled and included in any other schedule by the director pursuant to the director’s designation and rescheduling authority set forth in section 3 of P.L.1970, c.226 (C.24:21-3). (11) Mescaline (12) Peyote (13) N-ethyl-3-piperidyl benzilate (14) N-methyl-3-piperidyl benzilate (15) Psilocybin (16) Psilocyn (17) Tetrahydrocannabinols, including those produced by way of manufacture, except when found in hemp or a hemp product cultivated, handled, processed, transported, or sold pursuant to the "New Jersey Hemp Farming Act," P.L.2019, c.238 (C.4:28-6 et al.), or cannabis or a cannabis item, as those terms are defined in section 3 of P.L.2021, c.16 (C.24:6I-33), that is grown, cultivated, produced, manufactured, or sold in accordance with the "New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act," P.L.2021, c.16 (C.24:6I-31 et al.).
f21f99089f5bfc07e. Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) 3,4-methylenedioxy amphetamine (2) 5-methoxy-3,4-methylenedioxy amphetamine (3) 3,4,5-trimethoxy amphetamine (4) Bufotenine (5) Diethyltryptamine (6) Dimethyltryptamine (7) 4-methyl-2,5-dimethoxylamphetamine (8) Ibogaine (9) Lysergic acid diethylamide (10) Marijuana; except that on and after the effective date of the "New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act," P.L.2021, c.16 (C.24:6I-31 et al.), marijuana shall no longer be included in Schedule I and shall not be designated or rescheduled and included in any other schedule by the director pursuant to the director’s designation and rescheduling authority set forth in section 3 of P.L.1970, c.226 (C.24:21-3). (11) Mescaline (12) Peyote (13) N-ethyl-3-piperidyl benzilate (14) N-methyl-3-piperidyl benzilate (15) Psilocybin (16) Psilocyn (17) Tetrahydrocannabinols, including those produced by way of manufacture, except when found in hemp or a hemp product cultivated, handled, processed, transported, or sold pursuant to the "New Jersey Hemp Farming Act," P.L.2019, c.238 (C.4:28-6 et al.), or cannabis or a cannabis item, as those terms are defined in section 3 of P.L.2021, c.16 (C.24:6I-33), that is grown, cultivated, produced, manufactured, or sold in accordance with the "New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act," P.L.2021, c.16 (C.24:6I-31 et al.). L.1970, c.226, s.5; amended 2007, c.244, s.3; 2018, c.139, s.8; 2019, c.238, s.12; 2021, c.16, s.44; 2024, c.73, s.3.
45ba7ded3f4f75e8d. Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system: (1) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules (2) Chlorhexadol (3) Glutethimide (4) Lysergic acid (5) Lysergic acid amide (6) Methyprylon (7) Phencyclidine (8) Sulfondiethylmethane (9) Sulfonethylmethane (10) Sulfonmethane (11) Ketamine hydrochloride.
f95d8fa613f9d19524:6G-1. Control or possession without written permit; prohibition; exceptions
It shall be unlawful for any person or persons, except a duly licensed physician, dentist, veterinarian, nurse, hospital, sanitarium or other medical institution, or a resident physician or intern of a hospital, sanitarium or other medical institution, to have under control or possess nitrous oxide in any form unless the person obtains a written permit issued by the Department of Health; except that no person under 19 years of age shall have under his control or possess nitrous oxide.
L.1982, c. 127, s. 1, eff. Sept. 3, 1982.
24:6G-2. Sale of nitrous oxide for nonmedical use
2. When nitrous oxide is sold for nonmedical use, both the seller and buyer shall obtain a written permit issued by the Department of Health; except that if the seller is registered with the Department of Health as a distributor or wholesaler of nitrous oxide or if the nitrous oxide is to be used in food preparation, the seller or buyer does not have to obtain a permit. A permit shall contain the name, address and other location of the person who requests the permit and a registration number assigned by the Department of Health. The buyer shall state the intended use of the nitrous oxide on the permit.
Notwithstanding the provisions of sections 1 and 2 of this act, no person shall sell, distribute or dispense nitrous oxide to any person under 19 years of age.
L.1982,c.127,s.2; amended 1992,c.179.
24:6G-3. Record of sale; duration of retention; contents; inspection
Every person who sells or furnishes nitrous oxide shall retain a record of the sale for a period of 2 years. The record of the sales shall contain the name and address of the buyer, number of the buyer’s permit, date of sale and amount of nitrous oxide purchased. Records shall be open to inspection by any public officer or employee engaged in the enforcement of this section.
L.1982, c. 127, s. 3, eff. Sept. 3, 1982.
24:6G-4. Permits; purposes authorized
The Commissioner of Health is authorized to issue permits for the acquisition of nitrous oxide for the purposes enumerated in section 1 of this act.
L.1982, c. 127, s. 4, eff. Sept. 3, 1982.
24:6G-5. Administration and enforcement; rules
The Commissioner of Health shall administer and enforce the provisions of this act and shall issue all rules necessary to effectuate the purposes of this act.
L.1982, c. 127, s. 5, eff. Sept. 3, 1982.
24:6G-6. Violations; penalties; recovery and enforcement
The penalties for violating any provisions of this act shall be as provided in chapter 17 of Title 24 of the Revised Statutes. Such penalties shall be recovered and enforced in the same manner and in accordance with the procedure detailed in chapter 17 of Title 24 of the Revised Statutes. In addition, any person violating the provisions of this act may be sentenced to imprisonment for a definite term which shall be fixed by the court and shall not exceed 6 months.
L.1982, c. 127, s. 6, eff. Sept. 3, 1982.
2C:35-10.4 Toxic chemicals.
7. Toxic Chemicals a. As used in this section the term "toxic chemical" means any chemical or substance having the property of releasing toxic fumes. "Toxic chemical" includes, but is not limited to, acetone, acetate, benzene, butyl alcohol, ethyl alcohol, ethylene dichloride, isopropyl alcohol, methyl alcohol, methyl ethyl ketone, nitrous oxide, pentachlorophenol, petroleum ether, toluol, toluene and any glue, cement, adhesive, paint remover or other substance containing a chemical capable of releasing vapors or fumes causing a condition of intoxication, inebriation, excitement, stupefaction, or dulling of the brain or nervous system.
b. A person commits a disorderly persons offense if the person:
(1) inhales the fumes of any toxic chemical for the purpose of causing a condition of intoxication; or
(2) possesses any toxic chemical for the purpose of causing a condition of intoxication.
This subsection shall not apply to the possession and use of nitrous oxide or any material containing nitrous oxide for the purpose of medical, surgical, or dental care by a person duly licensed to administer nitrous oxide.
c. A person commits a fourth degree offense if the person sells, or offers to sell, any substance containing a toxic chemical knowing that the intended use of the product is to cause a condition of intoxication, or knowing that the product does not include an additive required by the Commissioner of the State Department of Health and Senior Services to discourage the inhalation of vapors of toxic chemicals for the purpose of causing a condition of intoxication. This subsection does not apply to adhesives manufactured only for industrial application or to the sale of nitrous oxide or any material containing nitrous oxide lawfully distributed pursuant to sections 1 though 6 of P.L.1982, c.127 (C.24:6G-1 et seq.).
L.1999,c.90,s.7; amended 2007, c.31, s.1.c2888ab90ee0371c2C:35-10.4 Toxic chemicals. 7. Toxic Chemicals a. As used in this section the term "toxic chemical" means any chemical or substance having the property of releasing toxic fumes. "Toxic chemical" includes, but is not limited to, acetone, acetate, benzene, butyl alcohol, ethyl alcohol, ethylene dichloride, isopropyl alcohol, methyl alcohol, methyl ethyl ketone, nitrous oxide, pentachlorophenol, petroleum ether, toluol, toluene and any glue, cement, adhesive, paint remover or other substance containing a chemical capable of releasing vapors or fumes causing a condition of intoxication, inebriation, excitement, stupefaction, or dulling of the brain or nervous system. b. A person commits a disorderly persons offense if the person: (1) inhales the fumes of any toxic chemical for the purpose of causing a condition of intoxication; or (2) possesses any toxic chemical for the purpose of causing a condition of intoxication. This subsection shall not apply to the possession and use of nitrous oxide or any material containing nitrous oxide for the purpose of medical, surgical, or dental care by a person duly licensed to administer nitrous oxide. c. A person commits a fourth degree offense if the person sells, or offers to sell, any substance containing a toxic chemical knowing that the intended use of the product is to cause a condition of intoxication, or knowing that the product does not include an additive required by the Commissioner of the State Department of Health and Senior Services to discourage the inhalation of vapors of toxic chemicals for the purpose of causing a condition of intoxication. This subsection does not apply to adhesives manufactured only for industrial application or to the sale of nitrous oxide or any material containing nitrous oxide lawfully distributed pursuant to sections 1 though 6 of P.L.1982, c.127 (C.24:6G-1 et seq.). L.1999,c.90,s.7; amended 2007, c.31, s.1.
b16e837424533ac6“Controlled dangerous substance” means a drug, substance, or immediate precursor in Schedules I through V, marijuana and hashish as defined in this section, any substance the distribution of which is specifically prohibited in N.J.S.2C:35-3, in section 3 of P.L.1997, c.194 (C.2C:35-5.2), in section 5 of P.L.1997, c.194 (C.2C:35-5.3), in section 2 of P.L.2011, c.120 (C.2C:35-5.3a), or in section 2 of P.L.2013, c.35 (C.2C:35-5.3b), and any drug or substance which, when ingested, is metabolized or otherwise becomes a controlled dangerous substance in the human body. When any statute refers to controlled dangerous substances, or to a specific controlled dangerous substance, it shall also be deemed to refer to any drug or substance which, when ingested, is metabolized or otherwise becomes a controlled dangerous substance or the specific controlled dangerous substance, and to any substance that is an immediate precursor of a controlled dangerous substance or the specific controlled dangerous substance. The term shall not include distilled spirits, wine, malt beverages, as those terms are defined or used in R.S.33:1-1 et seq., tobacco and tobacco products, or cannabis and cannabis as defined in section 3 of P.L.2021, c.16 (C.24:6I-33). The term, wherever it appears in any law or administrative regulation of this State, shall include controlled substance analogs. “Controlled substance analog” means a substance that has a chemical structure substantially similar to that of a controlled dangerous substance and that was specifically designed to produce an effect substantially similar to that of a controlled dangerous substance. The term shall not include a substance manufactured or distributed in conformance with the provisions of an approved new drug application or an exemption for investigational use within the meaning of section 505 of the “Federal Food, Drug and Cosmetic Act,” 52 Stat. 1052 (21 U.S.C. s.355).
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · RSS · Data licensing · llms.txt · Sitemap